%0 Journal Article
%T Are Mesenchymal Cells Indeed Pluripotent Stem Cells or Just Stromal Cells? OCT-4 and VSELs Biology Has Led to Better Understanding
%A Deepa Bhartiya
%J Stem Cells International
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/547501
%X Stem cells have excited researchers because of their potential to regenerate. However, which stem cells will be the best candidate for regenerative medicine remains an enigma. Compared to pluripotent stem cells with associated risks of immune rejection and teratoma formation, adult stem cells especially the mesenchymal stem cells (MSCs) are hyped to be a suitable alternate since they also exhibit pluripotent properties. This review shows that there is a subpopulation of pluripotent very small embryonic-like stem cells (VSELs) among MSCs culture. The two populations differ from each other in expression pattern of OCT-4. VSELs exhibit nuclear OCT-4A, whereas the MSCs have cytoplasmic OCT-4B, similar to our earlier findings in testis and ovary. Pluripotent VSELs with nuclear OCT-4A exist in various adult body organs, and the immediate progenitors express cytoplasmic OCT-4B which is eventually lost as the cell differentiates further. To conclude it is essential to discriminate between nuclear and cytoplasmic OCT-4 expression and also to acknowledge the presence of VSELs. 1. Introduction Stem cells represent a novel cell type in the body which has the potential to regenerate any worn out tissue and maintain tissue homeostasis. Stem cells can be multiplied in large numbers in vitro and may serve to replace the damaged cells for regeneration rather than the existing means of managing diseases by treating the damaged cells with drugs. Stem cells are broadly classified based on their source into embryonic (hESCs) and adult (ASCs) stem cells. Embryonic stem cells are pluripotent in nature and can be differentiated into 200 odd cell types in the body belonging to the three germ layers, namely, ectoderm, endoderm, and mesoderm. On the other hand adult stem cells are isolated from adult body tissues and are multi- to unipotent in nature. Since the initial isolation of hES cell lines [1], there has been a divide amongst the embryonic and adult stem cell biologists. It has been the endeavor of the adult stem cell biologists to demonstrate that ASCs are equally good compared to hES cells, and thus hES cell research is not required (because of associated ethics since spare human embryos are used and manipulated). In January 2013, hES cell biologists were greatly relieved, when US Supreme Court refused to hear a case that could have prohibited government funding for hES cells [2]. Various approaches have been used to demonstrate that ASCs can replace hES cells. In particular with the ability to reprogram adult somatic cells to pluripotent state by iPS technology, the
%U http://www.hindawi.com/journals/sci/2013/547501/